|Articles|March 1, 2011
- Pharmaceutical Executive-03-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - March 2011
Castellani Takes Charge at PhRMA
Advertisement
Articles in this issue
almost 15 years ago
PICASSO—Truly a Work of Artalmost 15 years ago
The Netherlands: Innovation through Collaborationalmost 15 years ago
Restructured for Successalmost 15 years ago
The "Other" Innovationalmost 15 years ago
Where have all the Scientists Gone?almost 15 years ago
Making Sense of Market Chaosalmost 15 years ago
Pharm Exec's Seventh Annual Media Auditalmost 15 years ago
New Tools Track Safety, Value in Medicinealmost 15 years ago
A Rule of Thumb Gets Shot Downalmost 15 years ago
John Castellani: Industry's Level Bet on a Dizzying FutureNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharma Companies Raise List Prices, Including 16 That Had Agreements to Lower Prices with Trump Administration: Report
2
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
3
What is Daiichi Sankyo’s Strategy for Preparing for the JP Morgan Healthcare Conference?
4
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
5